[Hemostatic therapy in a patient with acquired von Willebrand disease and Waldenström disease with plasmapheresis and DDAVP].
A 73-year old patient suffering from IgM-paraproteinemia, plasma hyperviscosity, and acquired v. Willebrand's disease developed two consecutive bleeding episodes. He was treated by double-bag plasmapheresis and double-bag plasmapheresis combined with DDAVP. This combined therapy was superior to plasmapheresis alone, since bleeding ultimately stopped and did not reoccur. Thus, labour and expense of large volume plasma exchange and the costs of F VIII therapy could be prevented.
Thies
K
K
Institut für Transfusionsmedizin und Immunhämatologie, Klinikum der Stadt Ludwigshafen.
Budde
U
U
Hellstern
P
P
D000368:Aged; D001809:Blood Viscosity / Q000187:drug effects; D003131:Combined Modality Therapy; D003894:Deamino Arginine Vasopressin / Q000008:administration & dosage*; D006474:Hemorrhagic Disorders / Q000097:blood / Q000628:therapy*; D006801:Humans; D008297:Male; D010956:Plasmapheresis; D008258:Waldenstrom Macroglobulinemia / Q000097:blood / Q000628:therapy*; D014842:von Willebrand Diseases / Q000097:blood / Q000628:therapy*
D003894:Deamino Arginine Vasopressin
Blutstillende Therapie bei einem Patienten mit erworbener von-Willebrand-Erkrankung und M. Waldenström mit Plasmapherese und DDAVP.